Technology behind Covid tests to be developed to spot diabetes and Lyme disease

Aberdeen-based Vertebrate Antibodies Ltd is working with US biotech firm Innova Medical Group.

Lauren Gilmour
Wednesday 12 April 2023 19:11 BST
Experts who created the technology behind Covid tests are now turning their attention to conditions like diabetes and Lyme disease (Danny Lawson/PA)
Experts who created the technology behind Covid tests are now turning their attention to conditions like diabetes and Lyme disease (Danny Lawson/PA)

Experts who created the technology behind Covid tests at the height of the pandemic have joined forces with a US biotech firm to develop tests for other conditions such as diabetes and Lyme disease.

Formed by a group of research scientists at the University of Aberdeen, Vertebrate Antibodies Ltd (VAL) has secured investment with Innova Medical Group (IMG) to form a new holding company, EpitogenX.

EpitogenX aims to develop lab-based diagnostic tests for Lyme disease and diabetes, which are notoriously difficult to diagnose early enough to enable timely intervention.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in